findmyKOL

Francis Alenghat

Basic profile

University of Illinois Chicago

ORCIDNPI
RegionChicago, IL · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding2013–2021Why? →

Francis Alenghat is a Cardiology physician affiliated with University of Illinois Chicago. OpenAlex indexes 81 publications with 4,406 citations (h-index 21).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
81publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,406citations

Total citations across indexed works.

21h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2NIH grants · 2013–2021

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5841 S Maryland Ave
Chicago, IL 606371443

Telephone

888-824-0200

Registry record last updated 24 Oct 2022.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    85.9%
    Beta blocker24.3%
    Metoprolol Succinate59%Carvedilol26%Metoprolol Tartrate7%Bisoprolol Fumarate5%Atenolol4%
    Part D<11 patients
    Statin23.2%
    Atorvastatin Calcium57%Rosuvastatin Calcium39%Simvastatin4%
    Part D<11 patients

    + 10 more classes in this area

  • Blood & clotting

    11.3%
    Factor Xa inhibitor9.9%
    Eliquis78%Xarelto22%
    Part D34 patients
    P2Y12 inhibitor1.4%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    2.8%
    SGLT2 inhibitor2%
    Farxiga58%Jardiance42%
    Part D<11 patients
    GLP-1 receptor agonist0.8%
    Ozempic100%
    Part D<11 patients
Where care is delivered (Part B)77.1% facility · 22.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 20132021 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”